Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe page shows a new revision tag of v3.6.3, replacing the previous v3.6.0. This indicates a minor update to the page's revision history.SummaryDifference0.1%

- Check14 days agoChange DetectedThe related topics section had entries removed: 'Melanoma' and 'MedlinePlus Genetics', reducing the metadata shown about the study.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page now includes a note stating 'No longer looking for participants', signaling that enrollment for this study has closed. This contextualizes the study's current recruitment status for potential participants browsing the page.SummaryDifference0.6%

- Check28 days agoChange DetectedThe page footer credits were updated to remove the Moffitt branding and 'Helpful Links Provided by' attribution, and a new revision tag (Revision: v3.5.5) was added.SummaryDifference0.2%

- Check36 days agoChange DetectedThe related topics section loses entries for Melanoma and MedlinePlus Genetics and the related topics header is removed. This reduces cross-links to those topics on the page.SummaryDifference0.2%

- Check50 days agoChange DetectedMelanoma is added as a topic with related topics: MedlinePlus Genetics. The page revision tag is updated to v3.5.4 (replacing v3.5.3).SummaryDifference0.2%

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.